𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The relationship between prognosis and lymphocyte response to PHA in breast cancer

✍ Scribed by Bolton, P M; Whitehead, R H; Newcombe, R G; James, S L; Hughes, L E


Book ID
109833466
Publisher
Nature Publishing Group
Year
1975
Tongue
English
Weight
336 KB
Volume
31
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Relationship between T lymphocyte levels
✍ Thomas R. Jerrells; Jack H. Dean; Ronald B. Herberman πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 French βš– 757 KB

## Abstract Lung and breast cancer patients were studied for relationships between lymphocyte function, as measured by lymphoproliferative (LP)^3^ assays, and levels of circulating thymus‐derived lymphocytes (T lymphocytes) measured by rosette formation with sheep erythrocytes (E rosettes). LP resp

Apoptosis in breast cancer and its relat
✍ Nishimura, Reiki; Nagao, Kazuharu; Miyayama, Haruhiko; Matsuda, Masakazu; Baba, πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 396 KB πŸ‘ 1 views

Background and Objectives: Apoptosis is essential to maintain homeostasis in living organisms and occurs in a variety of tissues in response to both physiological and pathological stimuli. In breast cancer, most cytotoxic drugs and hormonal treatments induce apoptosis. We studied the relationships b

The relationship between slgM positive l
✍ Arnis Richters; Mimi Paller πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 303 KB

## Abstract The relative frequency of lymphocytes with surface immunoglobulins (sIgM, sIgG, sIgA) was studied in breast‐cancer patients' axillary lymph nodes by the immunofluorescence technique. The study encompassed a total of 105 patients, most of whom had infiltrating ductal carcinoma (IDC). The

Relationship between p53 gene abnormalit
✍ Ram Seshadri; Anthony S.-Y. Leong; Kieran McCaul; Frank A. Firgaira; Vittal Setl πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 757 KB

The prognostic significance of p53 gene abnormalities was investigated in 9 I9 primary breast-cancer patients. p53 expression and tumour-cell proliferation fraction determined by MIB-I count, p53 exon 5 and 6 mutations and HER-Z/neu oncogene amplification were detected by immunohistochemistry, PCR-S